SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Harwood AR, Hawkins NV, Rider WD, et al. Radiotherapy of early glottic cancer—I. Int J Radiat Oncol Biol Phys. 1979; 5: 473476.
  • 2
    Harwood AR, Tiere A. Radiotherapy of early glottic cancer—II. Int J Radiat Oncol Biol Phys. 1979; 5: 477482.
  • 3
    Horiot JC, Fletcher GH, Ballantyne AJ, et al. Analysis of failures in early vocal-cord cancer. Radiology. 1972; 103: 663665.
  • 4
    Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg CC. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys. 1990; 18: 13071313.
  • 5
    Lindelov B, Lauritzen AF, Hansen HS. Stage I glottic carcinoma: an analysis of tumor recurrence after primary radiotherapy. Clin Oncol. 1990; 2: 9496.
  • 6
    Lusinchi A, Dube P, Wibault P, et al. Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiother Oncol. 1989; 15: 313319.
  • 7
    Mendenhall WM, Parsons TJ, Million RR, Fletcher GH. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys. 1988; 15: 12671273.
  • 8
    Epstein BE, Lee DJ, Kashima H, Johns ME. Stage T1 glottic carcinoma: results of radiation therapy or laser excision. Radiology. 1990; 175: 567570.
  • 9
    Hirano M, Mori K, Iwashita H. Voice in laryngeal cancer. In: SmeeR, BridgerP, editors. Laryngeal cancer. Amsterdam: Elsevier Science, 1994: 5464.
  • 10
    Basi Scientifiche per la Definizione delle Linee Guida in Ambito Clinico per i Tumori Epiteliali della Testa e del Collo. Progetto finalizzato applicazioni cliniche della ricerca oncologica. Rome: Consiglio Nazionale Richerche, 1999.
  • 11
    Remacle M, Eckel HE. Suggested classification of endoscopic laryngeal oncological surgery. Curr Opin Otolaryngol Head Neck Surg. 2000; 8: 122129.
  • 12
    SobinLH, WittekindC, editors. TNM classification of malignant tumors, 6th edition. New York: John Wiley & Sons, 2002.
  • 13
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 14
    Peto R, Pike MC, Armitage P. Design and analysis of clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977; 35: 139.
  • 15
    Cox DR. Regression models and life tables. J R Stat Soc B. 1972; 34: 187220.
  • 16
    Harwood AR, Beale FA, Cummings BJ, Keane TJ, Rider WD. T2 glottic cancer. An analysis of dose-time volume factors. Int J Radiat Oncol Biol Phys. 1981; 7: 15011505.
  • 17
    Foote RL, Grado GL, Buskirk SJ, et al. Radiation therapy for glottic cancer using 6-MV photons. Cancer. 1996; 77: 381386.
  • 18
    Medini E, Medini A, Gapany M, Levitt SH. Radiation therapy in early carcinoma of the glottic larynx T1 N0 M0. Int J Radiat Oncol Biol Phys. 1996; 36: 12111213.
  • 19
    Kanonier G, Fritsch E, Rainer T, Thumfart WF. Radiotherapy in early glottic carcinoma. Ann Otol Rhinol Laryngol. 1996; 105: 759763.
  • 20
    Burke LS, Greven KM, McGuirt WT. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys. 1997; 38: 10011006.
  • 21
    Marshak G, Brenner B, Shvero J, et al. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys. 1999; 43: 10091013.
  • 22
    Yamamoto M, Joja I, Takemoto M, Kuroda M, Hiraki Y. The results of radiotherapy for T1 glottic cancers; influence of radiation beam energy. Acta Med Okayama. 1999; 53: 9194.
  • 23
    Cortes-Arroyo H, Rodriguez-Cuevas S, Labastida S. Quality control in planning and technique of radiotherapy with cobalt-60 for T1 glottic cancer increase local control and organ preservation. Am J Surg. 1997; 174: 477480.
  • 24
    Lee JH, Machtay M, McKenna MG, et al. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord. Am J Otolaryngol. 2001; 22: 4354.
  • 25
    Nozaki M, Furuta M, Murakami Y, et al. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure. Anticancer Res. 2000; 20: 11211124.
  • 26
    Reddy SP, Mohideen N, Marra S, Marks JE. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiother Oncol. 1998; 47: 161166.
  • 27
    Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys. 1997; 37: 10111021.
  • 28
    Hermans R, Van den Bogaert W, Rijnders A, Doornaert P, Baert AL. Predicting the local outcome of the glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography–determined tumor parameters. Radiother Oncol. 1999; 50: 3646.
  • 29
    Brouha XDR, Op De Coul B, Terhaard CHJ, Hordijk GJ. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol. 2000; 25: 215218.
  • 30
    Narajana A, Vaughan AT, Fisher SGI, Reddy SP. Second malignancies in early stage laryngeal cancer: results of long term follow-up [abstract]. Proc Am Soc Clin Oncol. 1998; 17: A1534.
  • 31
    Fujita M, Rudoltz MS, Canady DJ, et al. Second malignant neoplasia in patients with T1 glottic cancer treated with radiation. Laryngoscope. 1998; 108: 18531855.
  • 32
    Johansen LV, Grau C, Overgaard J. Glottic carcinoma—patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol. 2002; 63: 257267.